All Business articles – Page 20
-
BusinessUS chemical safety agency wants Arkema disaster to spark real change
Industry guidance is needed to help hazardous chemical facilities better prepare for extreme weather events like flooding, the CSB warns
-
BusinessUS sanctions threaten Iran–Europe petrochemical ties
Companies review their options after Trump administration’s withdrawal from nuclear deal
-
BusinessRural power champion
Clementine Chambon is the 2018 Chemistry World Entrepreneur of the Year for her work using bioenergy to solve environmental, social and gender challenges in rural India
-
BusinessUS senators launch probe of Novartis’ payments to Trump lawyer
Congress demands info from Novartis about its $1.2m in outflows to Michael Cohen, just as it was negotiating payments for its cancer drug
-
BusinessTrump lays out plan to slash drug costs
White House strategy to reduce pharmaceutical prices faces backlash from the industry, which cautions against the ‘far-reaching’ proposals
-
BusinessTakeda set to swallow Shire
Shire’s US revenue and rare diseases portfolio grab Japanese firm’s attention
-
BusinessBig business computing
Chemical and oil firms are using supercomputers to improve every part of their operations. Angeli Mehta reports
-
BusinessChemicals caught in the middle as tariffs loom
America’s chemicals and plastics industry stands to lose $5bn if US–China dispute escalates
-
BusinessDeal protects world’s biggest selling drug from biosimilar erosion
AbbVie and Samsung Bioepis resolve patent litigation over arthritis drug Humira
-
BusinessIndia creates national drugs database to address supply and quality issues
Regulatory body takes steps to reform how it manages and monitors pharmaceuticals
-
BusinessNovartis’ $8.7bn AveXis deal shows gene therapy appeal
Acquisition indicates the value of potentially permanent cures for inherited diseases
-
BusinessAkzoNobel sells off specialty chemicals arm in €10bn deal
Private equity firm Carlyle sees off several other bidders
-
BusinessFit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
-
BusinessUS steel and aluminium tariffs threaten chemical and plastics sectors
Trump administration to levy 25% tariff on steel and 10% on aluminium
-
BusinessBattery builders get the cobalt blues
Demand for battery metals surges on the back of a global appetite for electric vehicles
-
BusinessOutline for Europe’s first waste to methanol plant
Enerkem teams up with AkzoNobel and Air Liquide to turn rubbish into raw materials
-
BusinessIndian court seizes former Ranbaxy owners’ assets
Daiichi Sankyo inches closer to recovering money from Singh brothers
-
BusinessDowDupont names its three new separate businesses
Corteva Agriscience, Dow and DuPont will be what DowDuPont calls the three independent companies it will spin-off by June 2019
-
BusinessTakata settles with US states over faulty airbag inflators
States will forgo the $650m civil penalty in favour of victims
-
BusinessCompany profile: Ellutia
Ellutia takes GC beyond the ‘box-in-the-lab’, with its customised chromatography